The Management of Thyrotoxicosis in Pregnancy
- 29 August 1985
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 313 (9) , 562-565
- https://doi.org/10.1056/nejm198508293130907
Abstract
THYROID disease is much more common in women than in men, and hyperthyroidism occurring during pregnancy is not rare; its prevalence is about 0.2 per cent. Thyrotoxicosis results in a significant increase in the prevalence of low birth weight and a trend toward increased neonatal mortality.1 Graves' disease is the major cause of thyrotoxicosis in women of childbearing age, although other causes are possible, including trophoblastic tumors and hydatidiform mole.2 Patients with the thyrotoxicosis of Graves' disease tend to have remission during pregnancy and exacerbation during the postpartum period.3 An explanation for fluctuations in the intensity of Graves' disease during . . .Keywords
This publication has 41 references indexed in Scilit:
- THYROTOXICOSIS IN PREGNANCY: RESULTS OF TREATMENT BY ANTITHYROID DRUGS COMBINED WITH T4Clinical Endocrinology, 1983
- Origin of scalp vertex aplasia cutisThe Journal of Pediatrics, 1982
- Decreased Levels of Helper T CellsNew England Journal of Medicine, 1982
- Thyrotoxic crisis following eclampsia and induction of labourPostgraduate Medical Journal, 1982
- High Prevalence of Transient Post-Partum Thyrotoxicosis and HypothyroidismNew England Journal of Medicine, 1982
- Beta-Blockers in PregnancyNew England Journal of Medicine, 1981
- Neonatal Thyroid Function after Propylthiouracil Therapy for Maternal Graves' DiseaseNew England Journal of Medicine, 1981
- Effects on the neonate of propranolol administered during pregnancyThe Journal of Pediatrics, 1977
- Propranolol administration during pregnancy: Effects on the fetusThe Journal of Pediatrics, 1975
- Neonatal hypothyroidism and goiter in oneinfant of each of two sets of twins due to maternal therapy with antithyroid drugsThe Journal of Pediatrics, 1974